TRPM8 Antagonist (Compound 14) is a potent and selective TRPM8 antagonist, with an IC50 of 0.2 nM, used in the research of neuropathic pain syndromes. TRPM8 Antagonist potently inhibits menthol-induced increase in intracellular Ca2+ levels in Ca2+ fluorimetric assays in HEK293 cells stably expressing the rat isoform of TRPM8 channels (IC50, 40 nM).
TRP Channel Inhibitors Related Products:
AMG9810; SB366791; Rosiglitazone; HC-030031; Clemizole; Clemizole hydrochloride; AMG-517